Preterm Birth Prevention And Management Market To Be Worth US$ 2.78 Billion By 2029
DUBAI, United Arab Emirates, The global Preterm Birth Prevention and Management Market is estimated to be worth around US$ 1.41 Bn in 2022. With increasing adoption of preterm birth prevention and management therapeutics across both developed and developing regions, the overall market is anticipated to grow at 10.1% CAGR between 2022 and 2029, totaling a valuation of US$ 2 .78 Bn by 2029.
The global Preterm Birth Prevention and Management Market surpassed the valuation of US$ 1 Bn in 2022, with growth projected to see a robust CAGR of more than 9% through 2029. The preterm birth prevention drugs industry is observing a substantial surge in number of FDA-approved new generic copies of blockbuster drugs every year. This can be primarily attributed to favorable government policy framework and demographics, orphan drug designations, adoption of new combination therapies, and complications in the selection of one line of therapy.
Attribute | Details |
Preterm Birth Prevention and Management Market Estimated Size in 2022 | US$ 1.41 Bn |
Preterm Birth Prevention and Management Market Projected Size in 2029 | US$ 2.78 Bn |
Preterm Birth Prevention and Management Market Historical CAGR (2014-2021) | 7.9% |
Preterm Birth Prevention and Management Market Value-Based CAGR (2022-2029) | 10.1% |
Request
a report sample to gain comprehensive insights
at
https://www.futuremarketinsights.com/reports/sample/rep-gb-6457
Key Takeaways of the Study
- Development of higher complexity specific portfolios and consistent focus on areas of strength while working pipelines are the cornerstone for success in the preterm birth prevention market space.
- Ensuring preterm interventions and research given proportional focus, so funding is aligned with health burden to curb the mortality rate
- Makena, with various approvals for the treatment of preterm birth in potential female patient pool, contributed to the dominance of the progesterone therapy segment by therapy type in 2018 and continue to do so during the forecast period.
- Highly effective therapies with cost advantage over are expected to generate significant revenue in the long run.
- Majority of the global preterm birth cases have not been directed towards preterm diagnostic leading to higher mortality rates and complications
- Sale of Hydroxyprogesterone over antihypertensive drugs such as Nifedipine, and labetalol in the global preterm birth prevention and management market has increased drastically owing to quicker onset of action and higher efficacy.
Launch of Cost-effective Therapies Bodes Well for Market
New revenue opportunities in developed economies, and orphan drug designation by FDA are contributing significantly towards the launch of cost-effective therapies. A few other factors assisting the growth of preterm birth prevention and management market include adoption of preterm diagnostic tests and the economic burden of premature birth on the system.
Frequent drug shortages and unavailability of life-saving formulations in many parts of the country, growing initiatives by government and manufacturers for supply of life-saving preterm birth drugs, particularly in low income and developing countries, are driving the market growth.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-6457
Scope of the Report
Attribute | Details |
Historical Data Available for | 2014-2021 |
Forecast Period | 2022-2029 |
Market Analysis | Units for Volume and US$ Mn for Value |
Key Regions Covered | North America, Europe, Latin America, South Asia, East Asia, Oceania and Middle East and Africa |
Key Countries Covered | US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa |
Key Segments Covered | Therapy Type, Route of Administration, Patient Type, Distribution Channel, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
More Valuable Insights on Preterm birth prevention and management Market
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The global preterm birth prevention and management market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provide compelling insights on preterm birth prevention and management market on basis of therapy type (progesterone therapy, corticosteroid therapy, tocolytics therapy, antihypertensive therapy, magnesium sulfate therapy, heparin prophylaxis therapy, low-dose aspirin therapy, and antibiotics therapy) and by route of administration (Oral, Parenteral, and Vaginal) , and by patient type (prior spontaneous PTB, preeclampsia, short cervix, chronic hypertension, insulin-dependent, twins, antiphospholipid antibody syndrome, and others) and by distribution channel (hospital pharmacies, retail pharmacies, drug stores, and mail order pharmacies), across seven major regions.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-6457
Strategic Acquisitions by Key Players to Widen Regional Presence
The leading players in the preterm birth prevention and management market such as AMAG Pharmaceuticals, Pfizer Inc., and Mylan, are concentrating on organic revenue growth and commercial expansions by mergers and distribution agreements and capturing the untapped potential of the preterm birth prevention and management market.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Wearable Sensors For Animal Health Management Market - The use of wearable sensors for animal health management is increasingly becoming important. Various wearable sensors for animal health management are currently in different development stages.
Key Opinion Leader Management Market - Key opinion leaders (KOLs) are influential, trustworthy thought leaders who are held in high esteem. In the current scenario of the healthcare industry, an organization's success is related to its ability to build, maintain, and manage relationships with KOLs.
Infusion Pharmacy Management Market - Infusion therapy is type of medication through a needle or catheter. Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective.
Chronic Disease Management Services Market - Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering from the chronic or terminal health condition and require multidisciplinary care.
Scoliosis Management Market - Scoliosis is a medical disorder causing deformities in spine especially sideway curvature forming S or C shape in the spinal region. Scoliosis generally occurs during the pre-puberty phase.
Cardiac Rhythm Management Market - Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases. The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension.
Life Science Multichannel Campaign Management Market - Life science multichannel campaign management system helps companies to orchestrate, define and communicate their product offers to customers through social, mobile, call centres, direct mails and websites.
Insulin Management System Market - Frederick B and John M in 1923 were Nobel Prize awardee in Physiology or Medicine for discovery of Insulin. This serves a milestone in history of diabetes management as the death rate due to diabetes significantly reduced after its discovery.
Veterinary Pain Management Drugs Market - Veterinary pain management is a very important aspect of veterinary therapeutics. Animals suffer from pain, sometimes chronic, but however are unable to express it. Pain in animals could be associated with surgical pain, arthritis and cancer.
Population Health Management Platforms Market - It is an open secret that the healthcare industry, like many others, is undergoing dramatic changes. Information Technology has brought about sweeping changes in every aspect of our lives and healthcare is no exception.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/preterm-birth-prevention-and-management-market